Surgery Octreotide Temozolomide Bevacizumab Radiotherapy and Pegvisomant Treatment of an AIP Mutation‒Positive Child

摘要

ContextInactivating germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are linked to pituitary adenoma predisposition. Here, we present the youngest known patient with AIP-related pituitary adenoma.